Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors

By Famiglini Valeria   Coluccia Antonio   Brancale Andrea   Pelliccia Sveva   La Regina Giuseppe   Silvestri Romano  

Future Medicinal Chemistry, Vol. 5, Iss. 18, 2013-12 ,pp. : 2141-2156

Future Science

Access to resources Recommend Favorite

Investigation of Novel Lipid-Functionalized PNA Monomers as Potential HIV-1 Non-Nucleoside Reverse Transcriptase and/or Integrase Inhibitors

By Thomas Michael   Maga Giovanni   Mouscadet Jean-François   Howarth Nicola  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 26, Iss. 8-9, 2007-08 ,pp. : 1063-1066

Taylor & Francis Ltd

Access to resources Recommend Favorite

Structural Mechanisms of Drug Resistance for Mutations at Codons 181 and 188 in HIV-1 Reverse Transcriptase and the Improved Resilience of Second Generation Non-nucleoside Inhibitors

By Ren J.   Nichols C.   Bird L.   Chamberlain P.   Weaver K.   Short S.   Stuart D.I.   Stammers D.K.  

Journal of Molecular Biology, Vol. 312, Iss. 4, 2001-09 ,pp. : 795-805

Academic Press

Access to resources Recommend Favorite

Linear interaction energy approximation for binding affinities of nevirapine and HEPT analogues with HIV-1 reverse transcriptase

By Tavlarakis Antonios   Zhou Ruhong  

Molecular Simulation, Vol. 35, Iss. 15, 2009-12 ,pp. : 1224-1241

Taylor & Francis Ltd

Access to resources Recommend Favorite

The disposition and metabolism of GW695634: A non-nucleoside reverse transcriptase inhibitor (NNRTi) for treatment of HIV/AIDS

By de Serres Mark   Moss Lee   Sigafoos James   Sefler Andrea   Castellino Stephen   Bowers Gary   Serabjit-Singh Cosette  

Xenobiotica, Vol. 40, Iss. 6, 2010-06 ,pp. : 437-445

Informa Healthcare

Access to resources Recommend Favorite